These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Successful treatment of a complicated case of neuroleptic malignant syndrome. Lappa A, Podestà M, Capelli O, Castagna A, Di Placido G, Alampi D, Semeraro F. Intensive Care Med; 2002 Jul; 28(7):976-7. PubMed ID: 12122539 [Abstract] [Full Text] [Related]
14. [Beneficial effect of bromocriptine in a patient with malignant syndrome and hepatic dysfunctions]. Onaka A, Aibiki M, Shirakawa Y, Chikano S, Yokono S, Ogli K. Masui; 1993 Mar; 42(3):431-4. PubMed ID: 8468790 [Abstract] [Full Text] [Related]
15. [A cocaine-induced variant of the neuroleptic malignant syndrome. A case study]. Smidt MH, Collumbien EC. Tijdschr Psychiatr; 2006 Mar; 48(5):399-404. PubMed ID: 16956032 [Abstract] [Full Text] [Related]
16. Neuroleptic rechallenge following neuroleptic malignant syndrome. Raju GV, Ramesh Kumar TC, Khanna S. Aust N Z J Psychiatry; 2000 Aug; 34(4):700. PubMed ID: 10954411 [No Abstract] [Full Text] [Related]
17. [Neuroleptic malignant syndrome coinciding with acute toxoplasmosis]. Ortega Ortiz J, Cadevall Diéguez J, Mirón Ortega E. Med Clin (Barc); 1987 Mar 07; 88(9):388-9. PubMed ID: 3573861 [No Abstract] [Full Text] [Related]
19. [Neuroleptic malignant syndrome and related conditions]. Amore M, Montanari M. Minerva Psichiatr; 1992 Mar 07; 33(4):259-83. PubMed ID: 1363674 [Abstract] [Full Text] [Related]